Impact of stimulatory pathways on adipogenesis and HIV-therapy associated lipoatrophy

Experimental Biology and Medicine

Volumn 234, Issue 12, 2009, Pages 1484-1492

  Stankov, Metodi V ^a   Schmidt, Reinhold E ^a   Behrens, Georg M N ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Adipocyte differentiation; Antiretroviral therapy; IDV; Protease inhibitors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; DEXAMETHASONE; INDINAVIR; INSULIN; ISOBUTYLMETHYLXANTHINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENCY; FETAL CALF SERUM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MOUSE; NONHUMAN; PROADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MICE; PPAR GAMMA;

MURINAE;

EID: 72449208832     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0907-RM-205     Document Type: Article

References (32)

1. Rangwala SM, Lazar MA. Transcriptional control of adipogenesis. Annu Rev Nutr 20:535-559, 2000.
2. Mandrup S, Lane MD. Regulating adipogenesis. J Biol Chem 272:5367-5370, 1997.
3. Cornelius P, MacDougald OA, Lane MD. Regulation of adipocyte development. Annu Rev Nutr 14:99-129, 1994.
4. MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 64:345-373, 1995.
5. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145-171, 2000.
6. Kuri-Harcuch W, Green H. Adipose conversion of 3T3 cells depends on a serum factor. Proc Natl Acad Sci U S A 75:6107-6109, 1978. (Pubitemid 9093671)
7. Bastard JP, Caron M, Vidal H, Jan V, Auclair M, Vigouroux C, Luboinski J, Laville M, Maachi M, Girard PM, Rozenbaum W, Levan P, Capeau J. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 359:1026-1031, 2002. (Pubitemid 34286541)
8. Caron M, Auclair M, Vigouroux C, Glorian M, Forest C, Capeau J. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 50:1378-1388, 2001. (Pubitemid 32500171)
9. Gougeon ML, Penicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir Ther 9:161-177, 2004. (Pubitemid 38560209)
10. Boyd MA, Carr A, Ruxrungtham K, Srasuebkul P, Bien D, Law M, Wangsuphachart S, Krisanachinda A, Lerdlum S, Lange JM, Phanuphak P, Cooper DA, Reiss P. Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz. J Infect Dis 194:642-650, 2006. (Pubitemid 44297850)
11. Shankar SS, Bell LN, Steinberg HO, Considine RV. Four weeks of indinavir does not alter adipogenic transcription factors in healthy HIV-negative subjects. Antivir Ther 10:L20, 2005.
12. Green H, Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5:19-27, 1975.
13. Green H, Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7:105-113, 1976.
14. Stankov MV, Lucke T, Das AM, Schmidt RE, Behrens GM. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Antivir Ther 12:205-216, 2007. (Pubitemid 46569906)
15. Stankov MV, Schmidt RE, Behrens GM. Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion. Antimicrob Agents Chemother 52:2882-2889, 2008.
16. Lucke T, Hoppner W, Schmidt E, Illsinger S, Das AM. Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts. Mol Genet Metab 82:93-97, 2004. (Pubitemid 38523330)
17. Flexner C. HIV-protease inhibitors. N Engl J Med 338:1281-1292, 1998.
18. Lagathu C, Bastard JP, Auclair M, Maachi M, Kornprobst M, Capeau J, Caron M. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro. Antivir Ther 9:911-920, 2004. (Pubitemid 40040265)
19. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9:168-181, 1995.
20. Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Penicaud L. Drug-specific effect of nelfinavir and stavudine on primary culture of human preadipocytes. J Acquir Immune Defic Syndr 48:20-25, 2008. (Pubitemid 351600856)
21. Vernochet C, Azoulay S, Duval D, Guedj R, Cottrez F, Vidal H, Ailhaud G, Dani C. Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines. J Biol Chem 280:2238-2243, 2005.
22. Zen-Bio, Inc., Research Triangle Park, North Carolina. Zen-Bio: Subcutaneous Human Adipocytes: instruction manual ZBM0001.01 (2008). Available at: http://www.zen-bio.com/pdf/ZBM0001. 01SQAdipocyteCareRV08.08.pdf. Accessed June 30, 2009.
23. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352:48-62, 2005. (Pubitemid 40075680)
24. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846, 2006. (Pubitemid 46024990)
25. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 444:875-880, 2006. (Pubitemid 46028447)
26. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P. Dynamics of fat cell turnover in humans. Nature 453:783-787, 2008. (Pubitemid 351793777)
27. Brindle PK, Montminy MR. The CREB family of transcription activators. Curr Opin Genet Dev 2:199-204, 1992.
28. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538-1552, 1991. (Pubitemid 21906060)
29. Student AK, Hsu RY, Lane MD. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 255:4745-4750, 1980. (Pubitemid 10060752)
30. Prusty D, Park BH, Davis KE, Farmer SR. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277:46226-46232, 2002. (Pubitemid 35417614)
31. Tang QQ, Otto TC, Lane MD. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci U S A 100:44-49, 2003.
32. Bost F, Caron L, Marchetti I, Dani C, Marchand-Brustel Y, Binetruy B. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem J 361:621-627, 2002. (Pubitemid 34177831)